Login

Forgot your password?
New User?
Remember me
banner banner

You are here:Home » Antibodies » Abs to Annexin » Anti -Annexin I (Annexin A1, Annexin-1, Calpactin II, Calpactin-2, Chromobindin-9, Lipocortin I, Phospholipase A2 Inhibitory Protein, p35, ANXA1, ANX1, LPC1)

Anti -Annexin I (Annexin A1, Annexin-1, Calpactin II, Calpactin-2, Chromobindin-9,
Lipocortin I, Phospholipase A2 Inhibitory Protein, p35, ANXA1, ANX1, LPC1)

Pricing

  For pricing information, USA customers sign in.
  Outside USA? Please contact your distributor for pricing.

Specifications

Clone Host Grade Applications
Polyclonal Rabbit Affinity Purified B IH IC
The Annexins are a structurally related family of calcium-binding proteins that associate reversibly with membranes, and bind to phospholipid bilayers in the presence of micromolar free calcium concentrations. This binding is speci c for calcium and for acidic phospholipids. Each of the annexin proteins consist of an N-terminal domain of variable length followed by four or eight copies of a conserved segment of sixty one residues. The repeat (sometimes known as an 'endonexin fold') consists of ve alpha-helices that are wound into a right-handed superhelix. Annexins have been demonstrated to be involved in cytoskeletal interactions, phospholipase inhibition, intracellular signaling, anticoagulation, and membrane fusion. Although the annexins are primarily intracellular proteins and lack hydrophobic signal sequences, some family members (e.g. Annexin I and V) have been found to be secreted. Annexin I (calpactin II, chromobindin 9, GIF, Lipocortin, p35) is a cytoskeletal calcium-dependent phospholipid-binding protein which has been shown to be a mediator of corticosteroid activity, a substrate for serine/threonine kinases and growth regulated tyrosine kinases, and is may be involved in secretion. Although this protein has received considerable attention due to its potential involvement in a variety of pathways, research progress on the localization of Annexin I during development and in pathophysiological conditions has been hampered due to con icting reports on the immunolocalization of the protein. These contradictory data are believed to result in large part from unusual properties of the protein and its apparent sensitivity to different xation conditions.
Catalog #A2295-15A3
ApplicationsSuitable for use in Western Blot, Immunocytochemistry, and Immunohistochemistry. Other applications not tested.
Recommended DilutionWestern Blot:1-2ug/ml
Immunohistochemistry (paraffin):1-2ug/ml
Optimal dilutions to be determined by the researcher.
Storage and StabilityLyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Clone TypePolyclonal
IsotypeIgG
HostRabbit
SourceHuman
ConcentrationAs reported
FormSupplied as a lyophilized powder from PBS, pH 7.4, 5% BSA, 0.05% thimerosal, 0.05% sodium azide. Reconstitute with sterile dH2O.
PurityPurified by immunoaffinity chromatography.
ImmunogenSynthetic peptide corresponding to a sequence near the C-terminal of human Annexin I, different from the related rat and mouse sequence by two aa.
SpecificityRecognizes human Annexin I.
Important NoteThis product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.


External Links